Clinical Trial Update: Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/IIa clinical study of ApTOLL for acute ischemic stroke completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ApTOLL

Snippet

Sponsor: aptaTargets S.L. | Conditions: Stroke, Acute Stroke | Phase 1, Phase 2 | Status: COMPLETED